Similar articles

• Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.

  Grimes JD, Delgado MR. Grimes JD, et al. Clin Neuropharmacol. 1985;8(1):73-7. Clin Neuropharmacol. 1985. PMID: 3978651
• Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.

  Olsson JE. Olsson JE. Adv Neurol. 1990;53:421-3. Adv Neurol. 1990. PMID: 2239483 Clinical Trial. No abstract available.
• [Parlodel in early combination with levodopa in the treatment of Parkinson disease. Comparison of 2 dosage forms].

  Goulley F, Wolmark Y, Bourdeix I, Chaumet-Riffaud PD. Goulley F, et al. Therapie. 1993 May-Jun;48(3):233-8. Therapie. 1993. PMID: 7908147 Clinical Trial. French.
• Early dopamine agonist treatment in Parkinson's disease.

  Rinne UK. Rinne UK. Adv Neurol. 1990;53:417-9. Adv Neurol. 1990. PMID: 1978520 Review. No abstract available.
• Early combination therapy with bromocriptine and levodopa in Parkinson's disease.

  Factor SA, Weiner WJ. Factor SA, et al. Mov Disord. 1993 Jul;8(3):257-62. doi: 10.1002/mds.870080302. Mov Disord. 1993. PMID: 8341289 Review.